Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that’s 25 years of bringing you fearless, independent journalism. Since our first broadcast in 1996, Democracy Now! has refused to take corporate or government funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. If everyone who tunes in to Democracy Now! gave just $4, we could cover our operating expenses for the entire year. Really, that’s all it would take. Right now a generous donor will TRIPLE your donation, making it three times as valuable to Democracy Now! Please do your part today, and thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

FDA Panel to Review Pfizer’s Application for COVID Vaccines for Children

HeadlineOct 26, 2021

Moderna said Monday that two smaller-sized doses of its COVID-19 vaccine produced a powerful immune response in children enrolled in a clinical trial and proved to be safe for people as young as 6 years old. Moderna hasn’t yet publicly released its data, and the results are not yet peer reviewed.

Today an FDA advisory committee meets to review Pfizer’s application for emergency use of its COVID vaccine for U.S. children aged 5 to 11. Final approval from the CDC could come as soon as next week. The American Academy of Pediatrics reports about a quarter of all COVID-19 cases over the last week were among children, with over 118,000 infections. 

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top